.jpg)
Moody Neurorehabilitation Institute Acquires Wandercraft's Atalante X to Transform Care for Complex Patients
Moody Neurorehabilitation
.jpg)
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreement with Renault Group accelerates commercialization and advances Wandercraft's global robotics footprint.
Subscribe to our newsletter
0.jpg)
Wandercraft Personal Exoskeleton Achieves 100% Success Rate for Key Usability Tasks in New Study
RehabWeek 2025
Wandercraft Announces First Participants Enrolled in Clinical Trial of the World's First Self-Balancing Personal Exoskeleton
Landmark Study Advances Research on Hands-Free Exoskeleton Mobility for Individuals with Spinal Cord Injuries
Wandercraft Takes the Field at NVIDIA's "Super Bowl of AI
Wandercraft & AWS join forces at Nvidia GTC to demonstrates the Prototype Personal Exoskeleton
.png)
Wandercraft's Self-Balancing Exoskeleton Wins 2025 SXSW Innovation Award for Artificial Intelligence
SXSW Innovation Award for Artificial Intelligence
Wandercraft's Atalante X Enables Significant Gait Improvements in Post-Stroke Gait Rehabilitation in New Case Study
Post-Stroke Gait Rehabilitation in New Case Study
5.jpg)
Wandercraft's Personal Exoskeleton Honored as SXSW Innovation Award Finalist
SXSW Innovation Award Finalist 2025
Wandercraft Showcases First Self-Balancing Exoskeleton at 2024 Summer Olympic & Paralympic Torch Relay
Wandercraft Showcases First Self-Balancing Exoskeleton at 2024 Summer Olympic & Paralympic Torch Relay
.jpeg)
Medical robotics company Wandercraft receives €25 million in financing from EIB to advance self-balancing exoskeletal technology
Wandercraft receives €25 million in financing from EIB
Wandercraft's self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in patients with spinal cord injury
Wandercraft's self-balancing exoskeleton receives second FDA for rehabilitation in patients with spinal cord injury
Wandercraft unveils a groundbreaking innovation, its self-stabilizing Personal Exoskeleton, at an exclusive event in New York
Wandercraft unveils a groundbreaking innovation, its self-stabilizing Personal Exoskeleton, at an exclusive event in New York
Wandercraft launches new generation exoskeleton investigation
Wandercraft is a medical device company based in Paris.
How Robots Can Help People With Disabilities Walk Again #CNBC
Four-year-old Luz d'Luna Caro Quinteros-Pitts had only known life in a wheelchair until last summer, when her mom brought home a robotic gait-training device called Trexo.
Wandercraft equips Henri-Mondor with an Atalante exoskeleton thanks to the #ProtègeTonSoignant collective.
The AP-HP Henri-Mondor University Hospital Group chose Atalante to relieve its medical staff and rehabilitation services, which were severely strained during the peak of the COVID-19 epidemic, while optimising the walking rehabilitation treatments offered to its patients.
Wandercraft has been honored with the "Robot of the year" award
The robot of the year awards aim to encourage, select and support the development of the most promising innovations in artificial intelligence and robotics, designed for the benefit of human society and aligned with ethical criteria well defined in a number of key industrial sectors.